Enkhtsetseg Purev, Ph.D.
Affiliations: | 2005 | Temple University, Philadelphia, PA, United States |
Area:
Molecular BiologyGoogle:
"Enkhtsetseg Purev"Parents
Sign in to add mentor| Kenneth J. Soprano | grad student | 2005 | Temple University | |
| (The role of Rb2 /p130 and PP2A interaction in ATRA treatment induced growth arrest of ovarian carcinoma cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abramson JS, Palomba ML, Gordon LI, et al. (2020) Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet (London, England) |
| Sharma P, Purev E, Haverkos B, et al. (2020) Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant. Blood Advances. 4: 2227-2235 |
| Iyengar M, Purev E, Haverkos B, et al. (2020) Incidence of Pulmonary GVHD Is Increased and Incidence of Late Infection and Pulmonary Embolism Is Comparable Comparing Adult MRD Versus Cord Transplant Patients Biology of Blood and Marrow Transplantation. 26 |
| Winters AC, Gutman JA, Purev E, et al. (2019) Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia. Blood Advances. 3: 2911-2919 |
| Stevens BM, Zhang W, Pollyea DA, et al. (2019) CD123 CAR T Cells for the Treatment of Myelodysplastic Syndrome. Experimental Hematology |
| Gaikwad H, Wang G, Smith WJ, et al. (2019) Clickable Methyltetrazine-Indocarbocyanine Lipids: A Multicolor Tool Kit for Efficient Modifications of Cell Membranes. Bioconjugate Chemistry |
| Pei S, Pollyea DA, Gustafson A, et al. (2019) Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy Blood. 134: 185-185 |
| Gutman JA, Sharma P, Purev E, et al. (2019) Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Receiving Induction Only and Are Superior to MRD Positive Patients Receiving Induction and Additional Therapy Blood. 134: 4615-4615 |
| Winters A, Gutman JA, Purev E, et al. (2019) Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide Therapy Blood. 134: 2638-2638 |
| Lum J, Purev E, Gutman JA, et al. (2019) Successful Reduced Intensity Stem Cell Transplant in a Patient with Myeloproliferative Neoplasm/Myelodysplastic (MPN/MDS) Overlap Syndrome Diagnosed with West Nile Virus Encephalitis. Biology of Blood and Marrow Transplantation. 25 |